The FDA has issued new guidance that provides additional examples and clarity on human factors. The guidance may have implications for various areas, including digital health and medical devices, although its specific impact is unclear. Some outlets suggest the guidance could affect the development of certain therapies and products, such as cell and gene therapy and wearables, but the details and scope of the changes are not entirely clear.